News/Reuters/GSK Canada Submits Respiratory Syncytial Virus Vaccine Candidate…GSK Canada Submits Respiratory Syncytial Virus Vaccine Candidate For Regulatory ReviewNov 26, 202200:12 UTCGSKGSK plc GSK:GSK CANADA SUBMITS RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE FOR REGULATORY REVIEW